Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

被引：0
|
作者：
Schmidt, MK
van Sprundel, TC
Rookus, MA
Brohet, R
van Asperen, CJ
Rutgers, EJT
Tollenaar, RAEM
van't Veer, LJ
机构：
[1] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands
[4] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands
来源：
BREAST CANCER RESEARCH | 2005年 / 7卷 / Suppl 2期
关键词：
Breast Cancer; Contralateral Breast Cancer; BRCA2 Mutation Carrier; Mutation Testing; Contralateral Prophylactic Mastectomy;
D O I：
10.1186/bcr1096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
    MK Schmidt
    TC van Sprundel
    MA Rookus
    R Brohet
    CJ van Asperen
    EJTh Rutgers
    RAEM Tollenaar
    LJ van 't Veer
    Breast Cancer Research, 7
  • [2] Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
    van Sprundel, TC
    Schmidt, MK
    Rookus, MA
    Brohet, R
    van Asperen, CJ
    Rutgers, EJT
    van't Veer, L
    Tollenaar, RAEM
    BRITISH JOURNAL OF CANCER, 2005, 93 (03) : 287 - 292
  • [3] Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers
    T C van Sprundel
    M K Schmidt
    M A Rookus
    R Brohet
    C J van Asperen
    E J Th Rutgers
    L J van‘t Veer
    R A E M Tollenaar
    British Journal of Cancer, 2005, 93 : 287 - 292
  • [4] International Rates of Breast Reconstruction After Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers
    John Semple
    Kelly A. Metcalfe
    Henry T. Lynch
    Charmaine Kim-Sing
    Leigha Senter
    Tuya Pal
    Peter Ainsworth
    Jan Lubinski
    Nadine Tung
    Charis Eng
    Donna Gilchrist
    Joanne Blum
    Susan L. Neuhausen
    Christian F. Singer
    Parviz Ghadirian
    Ping Sun
    Steven A. Narod
    Annals of Surgical Oncology, 2013, 20 : 3817 - 3822
  • [5] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    K Metcalfe
    S Gershman
    H T Lynch
    P Ghadirian
    N Tung
    C Kim-Sing
    O I Olopade
    S Domchek
    J McLennan
    A Eisen
    W D Foulkes
    B Rosen
    P Sun
    S A Narod
    British Journal of Cancer, 2011, 104 : 1384 - 1392
  • [6] Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K.
    Gershman, S.
    Lynch, H. T.
    Ghadirian, P.
    Tung, N.
    Kim-Sing, C.
    Olopade, O. I.
    Domchek, S.
    McLennan, J.
    Eisen, A.
    Foulkes, W. D.
    Rosen, B.
    Sun, P.
    Narod, S. A.
    BRITISH JOURNAL OF CANCER, 2011, 104 (09) : 1384 - 1392
  • [7] Clinical management of BRCA1 and BRCA2 mutation carriers
    Domchek, S. M.
    Weber, B. L.
    ONCOGENE, 2006, 25 (43) : 5825 - 5831
  • [8] The clinical management of BRCA1 and BRCA2 mutation carriers
    Anthony P. Gulati
    Susan M. Domchek
    Current Oncology Reports, 2008, 10 : 47 - 53
  • [9] Clinical management of BRCA1 and BRCA2 mutation carriers
    S M Domchek
    B L Weber
    Oncogene, 2006, 25 : 5825 - 5831
  • [10] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    M Ahmed
    F Lalloo
    A Howell
    DG Evans
    Breast Cancer Research, 12
12345